Geneuity CRS and Molecular Pathology Laboratory Network Inc. Vice President Genomic Solutions Jamie Platt Ph.D., will be presenting at Biomarkers & Diagnostics World Congress 2015 in Philadelphia PA. May 7th . Dr. Platt will present on ‘Opportunities and Challenges for NGS-Based Clinical Trials’. Key challenges in NGS-based clinical trials will be discussed, and opportunities around assay validation, companion diagnostics, data analysis, genomic annotation and supporting services will be highlighted.

 

Opportunities and Challenges for NGS-Based Clinical Trials

Jamie L. Platt, Ph.D., Vice President, Genomic Solutions, Geneuity (an MPLN company)

The requirements and challenges for NGS-based diagnostics are different from those for NGS-based clinical trials. The evolving technology and regulatory landscapes present increased opportunity for utilizing NGS in clinical trials; however, a thorough understanding of workflow challenges, technical limitations and data analysis is required for optimal success. The key challenges in NGS-based clinical trials will be discussed, and opportunities around assay validation, companion diagnostics, data analysis, genomic annotation and supporting services will be highlighted.

Leave a Reply